Skip to main content
SABS logo

SABS · SAB Biotherapeutics, Inc.

$3.45 +0.01 (+0.29%) At close · Jul 28
Market Cap
$263.80M
Shares
76.46M

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

Filed Type Offering Sold
2025-08-05 New $175,000,000 $175,000,000
2023-10-16 New $7,500,000 $7,500,000
Showing 1–2 of 2 filings
Key facts CIK 1833214 CUSIP 78397T202 13F (30d) 6 filings 6 filers Visit website Investor relations